top of page
Follow us
Home
The Biomarker
DxPG80 Kit
Clinical
Clinical Data
Clinical Studies
Publications
Posters
About Us
Our History
Team
Contact
See more
Use tab to navigate through the menu items.
Publications
Publications
Progastrin: An Overview of Its Crucial Role in the Tumorigenesis of Gastrointestinal Cancers
April 2024
Plasma hPG
80
(circulating progastrin) as a novel biomarker for detecting gastric cancer: a Japanese multicenter study
March 2024
Association between post-operative hPG
80
(circulating progastrin) detectable level and worse prognosis in glioblastoma
October 2023
Plasma hPG
80
(Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort.
April 2023
hPG
80
(circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
January 2023
hPG
80
and cancer: A new blood biomarker in development for patient monitoring
June 2022
hPG
80
(Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
February 2022
Plasma hPG
80
(Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
January 2022
A novel method to detect hPG
80
(human circulating progastrin) in the blood
September 2021
Prognostic Value of Plasma hPG
80
(Circulating Progastrin) in Metastatic Renal Cell Carcinoma
January 2021
The oncogenic and druggable hPG
80
(Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
December 2019
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer
September 2017
bottom of page
